N-[2-[(2R)-5α-(3,4-Dihydro-2,4-dioxopyrimidin-1(2H)-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine

Englisch Name:: N-[2-[(2R)-5α-(3,4-Dihydro-2,4-dioxopyrimidin-1(2H)-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine

Synonyma:: Nikkomycin QZ;N-[2-[(2R)-5α-(3,4-Dihydro-2,4-dioxopyrimidin-1(2H)-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine;L-Homoserine, (3S,4S)-4-hydroxy-4-(5-hydroxy-2-pyridinyl)-L-valyl-(2S)-2-[(2R,3S,4R,5R)-5-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)tetrahydro-3,4-dihydroxy-2-furanyl]glycyl- (9CI);(2S)-2-[[(2S)-2-[[(2S,3S,4S)-2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutanoyl]amino]-2-[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]acetyl]amino]-4-hydroxybutanoic acid

Request For Quotation

Eigenschaften Sicherheit Verwendungswort

Eigenschaften Sicherheit Verwendungswort Suche Produkte:

N-[2-[(2R)-5α-(3,4-Dihydro-2,4-dioxopyrimidin-1(2H)-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine Eigenschaften

Global( 0)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate

N-[2-[(2R)-5α-(3,4-Dihydro-2,4-dioxopyrimidin-1(2H)-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine
Nikkomycin QZ
(2S)-2-[[(2S)-2-[[(2S,3S,4S)-2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutanoyl]amino]-2-[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]acetyl]amino]-4-hydroxybutanoic acid
L-Homoserine, (3S,4S)-4-hydroxy-4-(5-hydroxy-2-pyridinyl)-L-valyl-(2S)-2-[(2R,3S,4R,5R)-5-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)tetrahydro-3,4-dihydroxy-2-furanyl]glycyl- (9CI)
95259-50-0
C24H32N6O12